investment portfolio
Venture&Growth

Inari Medical

Inari has developed best-in-class technologies for the treatment of venous disease, starting with thrombectomy for Deep Vein Thrombosis and Pulmonary Embolism. Gilde led Inari’s Series C financing in March 2018, and invested because of the large, untapped market opportunity in venous thrombo-embolism and the high quality of the management team.

Ablative Solutions

Ablative Solutions is a medical device company that has developed a best-in-class drug delivery catheter,...

Ablynx

Ablynx is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based...

Acacia Pharma

Acacia Pharma is a revenue stage biopharmaceutical company focused on developing and commercializing novel products...

ADCendo

ADCendo is a Danish biopharmaceutical company developing antibody-drug conjugates (ADCs) for the treatment of cancers....

Agendia

Agendia markets a range of services to diagnose cancer. Agendia’s diagnostic tests predict the outcome...

AM-Pharma

AM-Pharma is a biopharmaceutical company developing a biotherapeutic for the treatment of Sepsis Associated Acute...

Amphista Therapeutics

Amphista Therapeutics is a UK-based biopharmaceutical company creating first-in-class therapeutics that harness the body’s natural...

Ascendis Pharma

Ascendis Pharma is a pharmaceutical company developing improved, patentable versions of high-value drugs. The company’s...

Axonics Modulation Technologies

Axonics Modulation Technologies is a medical device company that has developed a novel and best-in-class...

Loading...

These were all portfolio items

7fa93ceea8